Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 1,25(OH)2 Vitamin D3
Total 0 results
Nothing found
Sponsors and Collaborators
Neurophth Therapeutics Inc
RMIT University, Melbourne, Australia
Everett Meyer
Apollo Neuroscience, Inc.
Hospital ASEPEYO Sant Cugat
Kupfer, David J., M.D.
Mª Victoria Maestre Sanchez
Hospital Durand, Argentina
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Nacuity Pharmaceuticals, Inc.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
ASST Cremona, Cremona
GFI
Alma Lasers Inc.
Aptis Medical
Eurofins Genoma
Agency for Science, Technology and Research
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Korean Society of Spine Surgery
View Full List
Medical Conditions
Immune-Mediated Inflammatory Disease
Rheumatoid Arthritis(RA)
Dienogest
Treatment Decisions
Splenic Trauma
Corneal Cross-Linking
Chronic Constipation Symptoms
Metachronous Adenoma
Luteal Phase Support
Fever
The Strength Properties of the Aorta in Vitro
RISS Stage III Plasma Cell Myeloma
Gastric Cancer Stage IIIB-IIIC
Major Liver Surgery
Recurrent Clear Cell Sarcoma of Soft Tissue
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Disorder of Fluid Balance
Scleredema
T-LGL Leukemia
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
View Full List
Drug Interventions
Anticholinergic
Standard of care (SOC) for COVID-19
Oxycodone/acetaminophen 5/325 mg
Capecitabine/cisplatin
Desvenlafaxine
Olopatadine
Letrozole
TPN-101
Intravenous deferiprone
PD-1/PD-L1 inhibitor
THC
Midazolam
Intravenous Formulation of PD-0332991
OnabotulinumtoxinA
RDX227675
Fospropofol disodium, propofol
MLN2480
Capecitabine and IMRT (if randomized to this arm)
GLPG1837 multiple ascending doses
Camptosar
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in China
Contract Research Organizations in Denmark
Contract Research Organizations in Djibouti
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Ethiopia
Contract Research Organizations in Gabon
Contract Research Organizations in Mexico
Contract Research Organizations in Mongolia
Contract Research Organizations in Morocco
Contract Research Organizations in Oman
Contract Research Organizations in Taiwan
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Congo, DR of
SGS
ACROSS Global
All CROs in Congo, DR of
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe